He completed his undergraduate and graduate degrees at the Max Planck Institute for Medical Research/University of Heidelberg, Germany. He currently studies an enigmatic set of cells called glia, which are critically involved in many injuries and diseases including spinal-cord injury, glioma, amyotrophic lateral sclerosis, and Alexander’s disease. Work in Dr. Nimmerjahn’s lab is centered on investigating the role of glial cells in information processing, regulation of vascular dynamics, and stroke. EMMANUELLE A. PASSEGUÉ